Court Extends Deadline for Claims Vs. Bristol-Myers

Law360, New York (November 14, 2003, 12:00 AM EST) -- The U.S. District Court for the District of Columbia has given cancer patients treated with Taxol (paclitaxel) another three months to file claims against Bristol-Myers Squibb for delaying generic competition by fraudulently obtaining patents, Idaho Attorney General Lawrence Wasden said in a statement.

Consumers who used Taxol between 1999 and February 2003 and their survivors now have until Jan. 31 to file a claim under a settlement agreement reached earlier this year.

The court has tentatively approved the settlement in the antitrust lawsuit filed by 29...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.